News
SMMNY
25.34
+1.16%
0.29
Siemens Healthineers: Healthcare Remains Attractive After 2025
Seeking Alpha · 19h ago
Jefferies Remains a Buy on Siemens Healthineers AG (SEMHF)
TipRanks · 1d ago
Siemens to spin off 30% of Healthineers to shareholders, refocus on software and digital
Seeking Alpha · 2d ago
Siemens Healthineers price target lowered to EUR 57 at Deutsche Bank
TipRanks · 2d ago
Siemens plans to deconsolidate Siemens Healthineers
TipRanks · 2d ago
Deutsche Bank Keeps Their Buy Rating on Siemens Healthineers AG (SEMHF)
TipRanks · 2d ago
Weekly Report: what happened at SMMNY last week (1103-1107)?
Weekly Report · 4d ago
DZ BANK AG Sticks to Its Buy Rating for Siemens Healthineers AG (SEMHF)
TipRanks · 6d ago
Siemens Healthineers AG (SEMHF) Gets a Buy from Barclays
TipRanks · 6d ago
Siemens reportedly eyeing a direct spinoff of Healthineers stake
Seeking Alpha · 11/07 19:38
Siemens Healthineers AG (SEMHF) Receives a Buy from J.P. Morgan
TipRanks · 11/07 07:05
Accuray's Latest Transformation Attempt Could Be Too Little Too Late
Seeking Alpha · 11/06 17:35
Siemens Healthineers Reports Solid Growth Amid Challenges
TipRanks · 11/06 05:42
UBS Keeps Their Hold Rating on Siemens Healthineers AG (SEMHF)
TipRanks · 11/05 11:19
Siemens Healthineers AG (SEMHF) Gets a Buy from Jefferies
TipRanks · 11/05 08:35
Siemens Healthineers reports Q4 results
Seeking Alpha · 11/05 07:16
Siemens Healthineers AG (SEMHF) Receives a Buy from Barclays
TipRanks · 11/03 10:35
Weekly Report: what happened at SMMNY last week (1027-1031)?
Weekly Report · 11/03 10:33
J.P. Morgan Remains a Buy on Siemens Healthineers AG (SEMHF)
TipRanks · 11/03 06:36
Weekly Report: what happened at SMMNY last week (1020-1024)?
Weekly Report · 10/27 10:38
More
Webull provides a variety of real-time SMMNY stock news. You can receive the latest news about Siemens Healthineers Ag through multiple platforms. This information may help you make smarter investment decisions.
About SMMNY
Siemens Healthineers AG is a Germany-based company. The Company is a global provider of healthcare products, solutions and services. It also provides clinical consulting services and training and service offerings. The Company’s segments include Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment offers a software solutions to support the reading and structured reporting of diagnostic images from different modalities. The Diagnostics segment offers to healthcare providers in the fields of general laboratory, specialty laboratory, and point-of-care diagnostics. The Varian segment offers a portfolio of cancer care technologies and services and support oncology departments in hospitals and clinics. The Advanced Therapies segment consists of integrated products, services and solutions used in the treatment of diseases across multiple clinical fields.